Francis Patrick Ostronic insider trades: Cyclo Therapeutics (CYTH) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Francis reports to the SEC
Open-market buys and sales
25 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 20, 2023 | CYTH | ↑ Buy | 59,881 | $0.71 | $43K | Direct | Apr 24, 2023 (4d) |
| Sep 21, 2022 | CYTH | ↑ Buy | 5,000 | $1.76 | $9K | Direct | Sep 22, 2022 (1d) |
| May 20, 2022 | CYTH | ↑ Buy | 5,000 | $2.04 | $10K | Direct | May 23, 2022 (3d) |
| Jan 24, 2022 | CYTH | ↑ Buy | 2,000 | $3.75 | $8K | Direct | Jan 24, 2022 (0d) |
| Jan 19, 2022 | CYTH | ↑ Buy | 1,132 | $4.00 | $5K | Direct | Jan 19, 2022 (0d) |
| Jan 14, 2022 | CYTH | ↑ Buy | 1,731 | $4.00 | $7K | Direct | Jan 18, 2022 (4d) |
| Jan 14, 2022 | CYTH | ↑ Buy | 2,137 | $4.00 | $9K | Direct | Jan 14, 2022 (0d) |
| Dec 15, 2021 | CYTH | ↑ Buy | 3,000 | $3.90 | $12K | Direct | Dec 15, 2021 (0d) |
| Dec 10, 2021 | CYTH | ↑ Buy | 5,000 | $4.40 | $22K | Direct | Dec 10, 2021 (0d) |
| Dec 3, 2021 | CYTH | ↑ Buy | 864 | $4.75 | $4K | Direct | Dec 6, 2021 (3d) |
| Dec 2, 2021 | CYTH | ↑ Buy | 4,136 | $4.75 | $20K | Direct | Dec 2, 2021 (0d) |
| Dec 1, 2021 | CYTH | ↑ Buy | 5,000 | $5.00 | $25K | Direct | Dec 1, 2021 (0d) |
| Nov 19, 2021 | CYTH | ↑ Buy | 10,652 | $5.25 | $56K | Direct | Nov 19, 2021 (0d) |
| Oct 29, 2021 | CYTH | ↑ Buy | 1,000 | $5.90 | $6K | Direct | Nov 1, 2021 (3d) |
| Apr 16, 2021 | CYTH | ↑ Buy | 10,000 | $6.53 | $65K | Direct | Apr 16, 2021 (0d) |
| Apr 12, 2021 | CYTH | ↑ Buy | 5,000 | $7.00 | $35K | Direct | Apr 12, 2021 (0d) |
| Mar 29, 2021 | CYTH | ↑ Buy | 3,000 | $7.53 | $23K | Direct | Mar 30, 2021 (1d) |
| Dec 17, 2020 | CYTH | ↑ Buy | 30,000 | $4.66 | $140K | Direct | Dec 17, 2020 (0d) |
| Apr 24, 2020 | CTDH | ↑ Buy | 1,000,000 | $0.10 | $100K | Direct | Apr 27, 2020 (3d) |
| Sep 16, 2019 | CTDH | ↑ Buy | 100,000 | $0.19 | $19K | Direct | Sep 18, 2019 (2d) |
| Sep 11, 2019 | CTDH | ↑ Buy | 1,000 | $0.18 | $180 | Direct | Sep 13, 2019 (2d) |
| Aug 28, 2019 | CTDH | ↑ Buy | 50,000 | $0.20 | $10K | Direct | Aug 29, 2019 (1d) |
| Aug 1, 2019 | CTDH | ↑ Buy | 200,000 | $0.23 | $47K | Direct | Aug 2, 2019 (1d) |
| Jul 31, 2019 | CTDH | ↑ Buy | 100,000 | $0.25 | $25K | Direct | Jul 31, 2019 (0d) |
| Jul 10, 2015 | CTDH | ↑ Buy | 100,000 | $0.50 | $50K | Direct | Jul 14, 2015 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Francis Patrick Ostronic's insider trades
Francis Patrick Ostronic is a director at Cyclo Therapeutics (CYTH). Since Jul 10, 2015, Francis has reported 25 open-market purchases worth $747K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (18 filings), other transactions (10 filings), option exercises (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CYTH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.